Digital Health, Mobile Health und Co. – Wertschöpfung durch Digitalisierung und Datenverarbeitung

Meister, Sven; Becker, Stefan; Leppert, Florian; Drop, Linus

doi:10.1007/978-3-658-12258-4_13

Cited by 29 publications

(21 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Wissenschaft und Wirtschaft haben zuletzt den Begriff der Industrie 4.0 geprägt, in der digitale Produkte und Innovationen prädominierend sind [3]. Die 4.0-Familie hat schnell Zuwachs aus dem Gesundheitswesen erhalten: Begriffe wie Gesundheit 4.0 oder Krankenhaus 4.0 stellen die Annahme auf, dass die bestehenden Herausforderungen, wie der demografische Wandel oder der Fachkräftemangel, faktisch durch Digitalisierung lösbar sind [4]. Die begriffliche Genese zur Digitalisierung im Gesundheitswesen kann auf nunmehr 40 Jahre historische Entwicklung verweisen, wie .…”

Section: Digitalisierung Und Digitale Reifeunclassified

Digitalisierung in der Mund‑, Kiefer- und Gesichtschirurgie

2020

View full text Add to dashboard Cite

Zusammenfassung Hintergrund Mit dem Digitale-Versorgung-Gesetz (DVG) und dem Patientendaten-Schutz-Gesetz (PDSG) wurden Gesetze zur Stärkung einer digital unterstützten Gesundheitsversorgung erlassen. Digitalisierung beansprucht, die Effektivität und Effizienz im Sinne der Leistungserbringerinnen und Leistungserbringer und Patientinnen und Patienten stärken zu können. Sie erfordert jedoch auch, Prozesse und Verantwortlichkeiten neu zu strukturieren, in Technologie zu investieren und digitale Kompetenzen sicherzustellen. Fragestellung Welche Chancen und Risiken ergeben sich durch Digitalisierung aus Sicht der Akteurinnen und Akteure der Mund‑, Kiefer- und Gesichts(MKG)-Chirurgie, und welcher Status quo ergibt sich im internationalen Vergleich? Material und Methode Anwendung von Experteninterviews (n = 8) als qualitatives Erhebungsinstrument und Durchführung einer strukturierten Literaturanalyse. Ergebnisse Digitalisierung hilft, Therapien zu optimieren (n = 7), wobei die digitale Bildgebung ein geschätztes Instrument (n = 8) in der MKG-Chirurgie ist. Es fehlen jedoch Angebote zur Aneignung digitaler Kompetenzen (n = 6), und zudem werden die Anforderungen des Datenschutzes (n = 4) kritisch gesehen. Schlussfolgerung Digitalisierung erfordert gerade zu Beginn hohe zeitliche und auch finanzielle Investitionen. Zudem sind neue Kompetenzen erforderlich, um Souveränität im Umgang mit digitalen Produkten sicherstellen zu können. Es wird angestrebt, die qualitativen Ergebnisse nachfolgend durch eine quantitative Analyse zu verifizieren.

show abstract

Section: Digitalisierung Und Digitale Reifeunclassified

Digitalisierung in der Mund‑, Kiefer- und Gesichtschirurgie

2020

View full text Add to dashboard Cite

show abstract

“…Telemedicine is a part of eHealth, defined as the use of information and communication technologies for health, which was developed in the 1990s [ 6 ]. Nowadays, the term digital health is recommended as it creates a link between digitalization, health, lifestyle, and community [ 7 ]. Telemedicine provides certain benefits, such as an improved access to health care services, an enhanced quality of health and care management, and potential cost and time efficiencies [ 8 ].…”

Section: Introductionmentioning

confidence: 99%

Clinical Improvements by Telemedicine Interventions Managing Type 1 and Type 2 Diabetes: Systematic Meta-review

Eberle¹,

Stichling²

2021

J Med Internet Res

View full text Add to dashboard Cite

Background Diabetes mellitus (DM) is one of the world’s greatest health threats with rising prevalence. Global digitalization leads to new digital approaches in diabetes management, such as telemedical interventions. Telemedicine, which is the use of information and communication technologies, may provide medical services over spatial distances to improve clinical patient outcomes by increasing access to diabetes care and medical information. Objective This study aims to examine whether telemedical interventions effectively improve diabetes control using studies that pooled patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), and whether the benefits are greater in patients diagnosed with T2DM than in those diagnosed with T1DM. We analyzed the primary outcome glycated hemoglobin A1c (HbA1c) and the secondary outcomes fasting blood glucose (FBG), blood pressure (BP), body weight, BMI, quality of life (QoL), cost, and time saving. Methods Publications were systematically identified by searching Cochrane Library, MEDLINE via PubMed, Web of Science Core Collection, Embase, and CINAHL databases for studies published between January 2008 and April 2020, considering systematic reviews (SRs), meta-analyses (MAs), randomized controlled trials (RCTs), and clinical trials (CTs). Study quality was assessed using the A Measurement Tool to Assess Systematic Reviews, Effective Public Health Practice Project, and National Institute for Health and Care Excellence qualitative checklist. We organized the trials by communication technologies in real-time video or audio interventions, asynchronous interventions, and combined interventions (synchronous and asynchronous communication). Results From 1116 unique citations, we identified 31 eligible studies (n=15 high, n=14 moderate, n=1 weak, and n=1 critically low quality). We selected 21 SRs and MAs, 8 RCTs, 1 non-RCT, and 1 qualitative study. Of the 10 trials, 3 were categorized as real-time video, 1 as real-time video and audio, 4 as asynchronous, and 2 as combined intervention. Significant decline in HbA1c levels based on pooled T1DM and T2DM patients data ranged from −0.22% weighted mean difference (WMD; 95% CI −0.28 to −0.15; P<.001) to −0.64% mean difference (95% CI −1.01 to −0.26; P<.001). The intervention effect on lowering HbA1c values might be significantly smaller for patients with T1DM than for patients with T2DM. Evidence on the impact on BP, body weight, FBG, cost effectiveness, and time saving was smaller compared with HbA1c but indicated potential in some publications. Conclusions Telemedical interventions might be clinically effective in improving diabetes control overall, and they might significantly improve HbA1c concentrations. Patients with T2DM could benefit more than patients with T1DM regarding lowering HbA1c levels. Further studies with longer duration and larger cohorts are necessary.

show abstract

“…The historical origins of digital health date back to the 1970s, when telematics, the science of telecommunications and informatics, emerged [ 1 ]. Telemedicine developed as a technology-supported physician-patient relationship in the 1970s/80s as a subarea of telematics.…”

Section: Introductionmentioning

confidence: 99%

Telemetric Interventions Offer New Opportunities for Managing Type 1 Diabetes Mellitus: Systematic Meta-review

Eberle¹,

Stichling²

2021

JMIR Diabetes

View full text Add to dashboard Cite

Background The prevalence of diabetes mellitus (DM) is increasing rapidly worldwide. Simultaneously, technological advances are offering new opportunities for better management of type 1 diabetes mellitus (T1DM). Telemetry, the remote acquisition of patient data via a telecommunication system, is a promising field of application in eHealth and is rapidly gaining importance. Objective The aim of this study was to summarize the current evidences available on the effectiveness of telemetric approaches in T1DM management. This systematic meta-review examined different types of interventions of the technologies used in communication between health care professionals and patients as well as the key outcomes. Methods We performed a systematic search in Web of Science Core Collection, EMBASE, Cochrane Library, MEDLINE via PubMed, and CINAHL databases in April 2020 with regard to the effectiveness of telemetric interventions for T1DM. We classified the interventions into 4 categories according to the technology used: (1) real-time video communication, (2) real-time audio communication, (3) asynchronous communication, and (4) combined forms of communication (real-time and asynchronous). We considered various study designs such as systematic reviews, clinical trials, meta-analyses, and randomized controlled trials and focused on the key outcomes. Additionally, a funnel plot based on hemoglobin A1c (HbA1c) values and different quality assessments were performed. Results We identified 17 (6 high quality and 9 moderate quality) eligible publications: randomized controlled trials (n=9), systematic reviews and meta-analyses (n=5), cohort studies (n=2), and qualitative publications (n=1). Of 12 studies, 8 (67%) indicated a (significant or nonsignificant) reduction in HbA1c levels; 65% (11/17) of the studies reported overall (mildly) positive effects of telemetric interventions by addressing all the measured outcomes. Asynchronous interventions were the most successful for patients diagnosed with T1DM, but no technology was clearly superior. However, there were many nonsignificant results and not sustained effects, and in some studies, the control group benefited from telemetric support or increased frequency of contacts. Conclusions Based on the currently available literature, this systematic meta-review shows that telemetric interventions cause significant reduction in HbA1c levels and result in overall positive effects in T1DM management. However, more specified effects of telemetric approaches in T1DM management should be analyzed in detail in larger cohorts.

show abstract

Digital Health, Mobile Health und Co. – Wertschöpfung durch Digitalisierung und Datenverarbeitung

Cited by 29 publications

References 11 publications

Digitalisierung in der Mund‑, Kiefer- und Gesichtschirurgie

Digitalisierung in der Mund‑, Kiefer- und Gesichtschirurgie

Clinical Improvements by Telemedicine Interventions Managing Type 1 and Type 2 Diabetes: Systematic Meta-review

Telemetric Interventions Offer New Opportunities for Managing Type 1 Diabetes Mellitus: Systematic Meta-review

Contact Info

Product

Resources

About